What is weight loss medication?
Weight loss medication, called slankemedicin or vægttabsmedicin in Danish, is prescription-only medicine for weight loss in obesity, or in overweight with a weight-related condition.
The medication is always used together with diet and exercise. It does not burn anything off by itself, but it makes it easier for you to eat less. When your appetite is dampened, it becomes easier to eat smaller portions in everyday life.
A doctor always assesses whether the treatment suits the individual. At Recepta the doctor goes through your health and your weight with you before a course of treatment is started.
What types of weight loss medication are there?
Weight loss medication comes as a weekly or daily pen and as daily tablets approved for weight loss in the EU.
Wegovy from Novo Nordisk contains an active substance (the active ingredient in the medicine) called semaglutide and is given with a pen once a week at a usual dose of 2.4 mg, while 7.2 mg is approved in the EU at a BMI (the ratio of weight to height) of 30 or above. Wegovy as a tablet, called the Wegovy pill, with 25 mg semaglutide daily, was approved in the EU on 15 July 2026 and came onto the Danish price list on 28 September 2026. Mounjaro from Eli Lilly contains tirzepatide as a weekly pen, and both Wegovy and Mounjaro are approved for weight loss in the EU. The same applies to Saxenda, with 3 mg liraglutide as a daily pen, which is older and less effective.[7][13]
Ozempic as a pen and Rybelsus as a tablet have the same active substance as Wegovy, but are approved for type 2 diabetes and not for weight loss. The older prescription-only weight loss pills Xenical with orlistat and Mysimba with naltrexone/bupropion give about 3 to 5% more weight loss than placebo (an inactive dummy treatment).
| Medicine | Active substance | Form | For weight loss |
|---|---|---|---|
| Wegovy | Semaglutide | Pen, weekly | Yes |
| Mounjaro | Tirzepatide | Pen, weekly | Yes |
| Wegovy pill | Semaglutide | Tablet, daily | Yes |
| Saxenda | Liraglutide | Pen, daily | Yes |
| Ozempic | Semaglutide | Pen, weekly | No |
| Rybelsus | Semaglutide | Tablet, daily | No |
"For weight loss" means approved for weight loss in the EU. Ozempic and Rybelsus are approved for type 2 diabetes and contain the same active substance as Wegovy.[7]
How does weight loss medication work?
Modern weight loss medication mimics gut hormones, which increase the feeling of fullness in the brain and make it easier to eat less.
The modern medicines mimic the gut hormone GLP-1 (a natural fullness hormone from the gut). GLP-1 tells the brain's appetite centre that you are full. At the same time, the hormone makes the stomach empty more slowly, so the feeling of fullness lasts longer after a meal.
Mounjaro mimics both GLP-1 and the gut hormone GIP (another hormone from the gut). The medication does not burn anything, but it makes it easier to eat less together with diet and exercise.
How much weight do you lose with weight loss medication?
In large studies, modern weight loss medication has given an average weight loss of up to 20.9%.
In the STEP 1 study, Wegovy at 2.4 mg gave an average weight loss of 14.9% after 68 weeks compared with 2.4% on placebo, and 86.4% lost at least 5% compared with 31.5% on placebo. The Wegovy pill at 25 mg gave 13.6% after 64 weeks in OASIS 4 compared with 2.2% on placebo. In SURMOUNT-1, Mounjaro at 15 mg gave 20.9% weight loss after 72 weeks compared with 3.1% on placebo.[1][5][2]
The main result in each of the five studies. Saxenda is an older medicine and is shown muted.[2][4][1][5][6]
The figures are averages from separate studies and cannot be compared directly. The exception is the SURMOUNT-5 study over 72 weeks, where Mounjaro in a direct comparison gave 20.2% weight loss compared with 13.7% on Wegovy. Each individual can always lose more or less than the average.[3]
Who can get weight loss medication?
Wegovy and Mounjaro are approved for adults with a BMI of 30 or above, or 27 with a weight-related condition.
At a BMI of 27 or above, at least one weight-related condition is required, such as high blood pressure, high cholesterol, sleep apnoea (pauses in breathing during sleep), prediabetes (an early stage of diabetes), type 2 diabetes or cardiovascular disease. A doctor always assesses whether the treatment suits the individual.[7]
The medication must not be used during pregnancy. Nor is it given if you are breastfeeding or planning a pregnancy. It is also not given to people who have had inflammation of the pancreas.
What side effects does weight loss medication have?
The most common side effects of weight loss medication are nausea, diarrhoea, constipation, stomach pain and vomiting.
The stomach and gut problems are seen mostly while the dose is stepped up, and they are usually mild to moderate and temporary. In the STEP 1 study, 4.5% on Wegovy stopped treatment because of stomach and gut problems, compared with 0.8% on placebo.[7][1]
Rare but serious side effects are inflammation of the pancreas and gallstones. Severe, persistent stomach pain must always be assessed by a doctor.
What does weight loss medication cost, and is there reimbursement (tilskud)?
As a rule, there is no reimbursement for weight loss medication in Denmark, so you pay the full pharmacy price yourself.
Pharmacy prices change every 14 days and are the same at all Danish pharmacies. You can see today's prices on Recepta's page Medication prices in Denmark, and the rules for reimbursement are in the post Reimbursement for weight loss medication.[13]
At Recepta the doctor consultation is free. The membership costs DKK 0 for the first 4 weeks and then from DKK 138 per 4 weeks. You buy the medication yourself at the pharmacy.
Can you get weight loss medication without a prescription, and how do you get a prescription online?
Weight loss medication cannot be bought legally without a prescription, but it can be prescribed after a video consultation with a doctor.
Never buy prescription-only medicine outside a Danish pharmacy or an online pharmacy registered with the Danish Medicines Agency (Lægemiddelstyrelsen). Products sold online without a prescription are illegal and often counterfeit.
Online at Recepta you answer questions about your height, weight and health and choose a time. The doctor consultation takes place by video, and if the doctor approves the treatment, the prescription is sent electronically to the pharmacy, where you collect and pay for the medication. The doctor follows up every 4 weeks.
What happens when you stop weight loss medication, and what is on the way?
After stopping weight loss medication many people regain weight, while others keep their weight, and new medicines are on the way.
In the extension of the STEP 1 study, about two-thirds of the weight loss had come back one year after stopping. In an analysis of 20,274 patients in the USA, however, 56.2% had kept their weight or continued to lose weight one year after stopping semaglutide. That is why the doctor plans a stop or a maintenance dose together with the patient.[8][9]
Two new medicines are on the way, but they are not yet available in Denmark. CagriSema from Novo Nordisk combines semaglutide and cagrilintide in one weekly injection and gave 21.0% weight loss after 68 weeks at 1.0 mg in the REDEFINE 9 study. Foundayo with orforglipron from Eli Lilly is a daily tablet that gave 11.2% weight loss after 72 weeks at the highest dose in ATTAIN-1, was recommended for approval in the EU on 16 October 2026 and is awaiting the European Commission's decision.[10][11][12]
Read also: Wegovy or Mounjaro: which is better? · What happens when you stop Wegovy or Mounjaro? · Reimbursement for weight loss medication: what can you get covered?
Questions and answers about weight loss medication
Are slankemedicin and vægttabsmedicin the same thing?
Are Wegovy and Ozempic the same?
What is the difference between a weight loss injection and weight loss pills?
How quickly does weight loss medication work?
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine 2021;384(11):989-1002. doi.org
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine 2022;387(3):205-216. doi.org
- Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine 2025;393(1):26-36. doi.org
- Wharton S, Freitas P, Hjelmesæth J, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). The Lancet Diabetes & Endocrinology 2025;13(11):949-963. doi.org
- Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine 2025;393(11):1077-1087. doi.org
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE). New England Journal of Medicine 2015;373(1):11-22. doi.org
- European Medicines Agency (EMA): Summary of product characteristics for Wegovy (semaglutide), sections 4.1, 4.2, 4.6 and 4.8. ema.europa.eu
- Ceriello A, Prattichizzo F, Mastan Sheik Abdullah AR, et al. Causes and consequences of discontinuation of GLP1RAs or tirzepatide. Nature Reviews Endocrinology 2026;22(9):530-542. doi.org
- Bartelt K, Mast C, Deckert J, Gracianette M, Joyce B. Many Patients Maintain Weight Loss a Year After Stopping Semaglutide and Liraglutide. Epic Research, 23 January 2024. epicresearch.org
- Wharton S, Broholm C, Horn D, et al. Efficacy and safety of co-administered cagrilintide-semaglutide (CagriSema) 1.7 mg each and 1.0 mg each in adults with overweight or obesity (REDEFINE 9). The Lancet Diabetes & Endocrinology, published online 14 November 2026. doi.org
- Wharton S, Aronne LJ, Stefanski A, et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment (ATTAIN-1). New England Journal of Medicine 2025;393(18):1796-1806. doi.org
- European Medicines Agency (EMA): New oral GLP-1 medicine for weight management and type 2 diabetes. News, 16 October 2026. ema.europa.eu
- Recepta: Medication prices in Denmark (the Danish price list). recepta.dk